Diarre var den mest almindelige bivirkning, der gav anledning til ophør med behandlingen, og denne havde den samme forekomst i begge grupper (lapatinib plus capecitabine:
Diarrhoea was the most common adverse reaction resulting in discontinuation of treatment and this had a similar incidence in both treatment groups (lapatinib plus capecitabine: